SFX by Ex Libris Inc.

Title:	Development and Properties of β-Glucuronide Linkers for Monoclonal Antibody−Drug Conjugates
Source:	Bioconjugate Chemistry [1043-1802] Jeffrey, Scott yr:2006

Basic

Full text

Full text available via American Chemical Society Journals

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Wei, G. "beta-glucuronidase-cleavable prodrugs of O-6-benzylguanine and O-6-benzyl-2 '-deoxyguanosine." Journal of medicinal chemistry 48.1 (2005): 256-261.
description	2.	Brich, Z. "Preparation and characterization of a water soluble dextran immunoconjugate of doxorubicin and the monoclonal antibody (ABL 364)." Journal of controlled release 19.1-3 (1992): 245-257.
description	3.	Inoh, K. "Doxorubicin-conjugated anti-midkine monoclonal antibody as a potential anti-tumor drug." Japanese Journal of Clinical Oncology 36.4 (2006): 207-211.
description	4.	TAKAHASHI, T. "MONOCLONAL ANTIBODY-DRUG CONJUGATE THERAPY FOR THE PATIENTS WITH COLORECTAL-CANCER." The Tohoku journal of experimental medicine 168.2 (1992): 371-374.
description	5.	Hanessian, S. "3-N,N-dimethylamino-3-deoxy lincomycin: A structure-based hybrid between lincomycin and the desosamine unit of erythromycin." Bioorganic & medicinal chemistry 13.17 (2005): 5283-5288.
description	6.	GRAAF, M. "A methylester of the glucuronide prodrug DOX-GA3 for improvement of tumor-selective chemotherapy." Biochemical Pharmacology 68.11 (2004): 2273-2281.
description	7.	Trikeriotis, M. "Intercalation of hydrophilic and hydrophobic antibiotics in layered double hydroxides." International Journal of Pharmaceutics 332.1-2 (2007): 176-184.
description	8.	Jayant, S. "Targeted sialic acid-doxorubicin prodrugs for intracellular delivery and cancer treatment." Pharmaceutical Research 24.11 (2007): 2120-2130.
description	9.	Choi, U. "Nuclear-localizing O-6-benzylguanine-resistant GFP-MGMT fusion protein as a novel in vivo selection marker." Experimental hematology 32.8 (2004): 709-719.
description	10.	Alley, Stephen C. "Antibody–drug conjugates: targeted drug delivery for cancer." Current opinion in chemical biology 14.4 (2010): 529-537.
description	11.	Safavy, Ahmad d. "Site-specifically traced drug release and biodistribution of a paclitaxel-antibody conjugate toward improvement of the linker structure." Bioconjugate chemistry 15.6 (2004): 1264-74.
description	12.	Suzawa, T. "Enhanced tumor cell selectivity of adriamycin-monoclonal antibody conjugate via a poly(ethylene glycol)-based cleavable linker." Journal of Controlled Release 79.1-3 (2002): 229-242.
description	13.	Bhadra, Pranab K. "Design, synthesis, and evaluation of stable and taste-free erythromycin proprodrugs." Journal of medicinal chemistry 48.11 (2005): 3878-3884.
description	14.	Johansson, S. "Elimination of HIV-1 infection by treatment with a doxorubicin-conjugated anti-envelope antibody." AIDS 20.15: 1911-1915.
description	15.	Rajeswaran, M. "Crystal and molecular structure and absolute configuration of lincomycin hydrochloride monohydrate." Carbohydrate Research 339.12 (2004): 2111-5.
description	16.	Hanessian, S. "Structure-based organic synthesis of drug prototypes: A personal odyssey." ChemMedChem 1.12 (2006): 1300-30.
description	17.	Ott, M. "Gene expression analysis identifies novel genes participating in early murine liver development and adult liver regeneration." Differentiation 74.4 (2006): 167-73.
description	18.	Paquet, V. "Significant improvement of antifungal activity of polyene macrolides by bisalkylation of the mycosamine." Organic letters 8.9 (2006): 1807-1809.
description	19.	Wang, G. "Synthesis and antibacterial activities of chiral 1,3-oxazinan-2-one derivatives." Bioorganic & medicinal chemistry letters 16.8 (2006): 2177-3.
description	20.	Saito, G. "Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities." Advanced Drug Delivery Reviews 55.2 (2003): 199-215.